Preeclampsia (PE) is a complex illness of the human gestation

Preeclampsia (PE) is a complex illness of the human gestation

Preeclampsia (PE) is a complex illness of the human gestation. It is responsible for a high perinatal morbimortality.It is the illness of the multiple theories; in one environmentaland genetic factors are associated to explain it. To find genes candidates to be associated with PE, two methodology ty...

Full description

Bibliographic Details
Main Authors:	Laura Gil Urbano, Juan Pablo Casas Romero, María Paula Martínez Linares, María Carolina Páez Leal, Norma Cecilia Serrano Díaz, Álvaro Andrés Navarro Mancilla
Format:	Article
Language:	Spanish
Published:	Universidad Autonoma de Bucaramanga 2002-12-01
Series:	MedUNAB
Subjects:	Genetics preeclampsia polimorphisms association studies binding studies methylenetetrahydrofolatereductase lipoprotein lipase endothelial nitric oxide sintase Leiden‘s V factor angiotensinogen HLA-G alpha tumoral necrosis factor.
Online Access:	http://caribdis.unab.edu.co/pls/portal/docs/PAGE/REVISTAMEDUNAB/NUMEROSANTERIORES/REVISTA515/PREECLAMPSIA.PDF

Similar Items

The Association between Preeclampsia and Defined Polymorphisms in Prothrombin and Coagulation Factor V Genes
by: Zohreh Salari, et al.
Published: (2016-09-01)

Association between Angiotensinogen M235T Polymorphism and Preeclampsia in Iranian Pregnant Women.
by: Raha Afshariani, et al.
Published: (2014-12-01)

Urinary Angiotensinogen-Melatonin Ratio in Gestational Diabetes and Preeclampsia
by: Gabriela Ribeiro Valias, et al.
Published: (2022-03-01)

Effects of factor v Leiden polymorphism on the pathogenesis and outcomes of preeclampsia
by: G. K. Ababio, et al.
Published: (2019-11-01)

Evaluation the frequency of factor V Leiden mutation in pregnant women with preeclampsia syndrome in an Iranian population
by: Azadeh Azinfar, et al.
Published: (2012-01-01)

HLA-G in Preeclampsia: a Pilot Study to Propose a Tolerogenic Treatment
by: César Lucio García, et al.
Published: (2018-07-01)

Factor de necrosis tumoral alfa en pacientes con preeclampsia a término y pretérmino
by: Eduardo Reyna Villasmil, et al.
Published: (2012-07-01)

Human Leukocyte Antigens in Pregnancy and Preeclampsia
by: Omonigho Aisagbonhi, et al.
Published: (2022-04-01)

Prevalence and Clinical Significance of Factor V Leiden Mutation in Egyptian Preeclamptic Women
by: Ahmed Alsheikh, et al.
Published: (2021-01-01)

Implication of Tumor Necrosis Factor - Alpha in Preeclampsia
by: Dan MIHU, et al.
Published: (2008-12-01)

Faktör V Leiden Mutasyonu ve Lipoprotein A Yüksekliğinin Bir Arada Olduğu Genç Yaş Miyokard İnfarktüsü
by: Abdulmelik YILDIZ, et al.
Published: (2013-09-01)

Effects of aqueous saffron extract on glucoregulation as well as hepatic agt and TNF-α gene expression in rats subjected to sub-chronic stress
by: Yeganeh Yazdani, et al.
Published: (2023-01-01)

HLA class Ib molecules and immune cells in pregnancy and preeclampsia
by: Snezana eDjurisic, et al.
Published: (2014-12-01)

Association of AGT (T704C) and NOS3 (G894T) Gene Polymorphisms with Treatment-Resistant Hypertension in the Uzbek Population
by: Sh. M. Masharipov, et al.
Published: (2023-06-01)

Clopidogrel resistance and genetic factors
by: Alev Arat Özkan
Published: (2013-07-01)

Association of Deficiency of Coagulation Factors (Prs, Prc, ATIII) and FVL Positivity with Preeclampsia and/or Eclampsia in Pregnant Women
by: Maryam Al-E-Rasul Dehkordi, et al.
Published: (2014-12-01)

Relationship between human leukocyte antigen (HLA)-DQA1*0102/HLA-DQB1*0602 polymorphism and preeclampsia
by: Mahmoud Mohammadi, et al.
Published: (2017-09-01)

Lipoprotein turnover and possible remnant accumulation in preeclampsia: insights from the Freiburg Preeclampsia H.E.L.P.-apheresis study
by: Christine Contini, et al.
Published: (2018-03-01)

Factor V Leiden Mutation and its Impact on Pregnancy Complications
by: Ľubica Hammerová, et al.
Published: (2011-01-01)

Foetal lipoprotein oxidation and preeclampsia
by: LA Gil-Acevedo, et al.
Published: (2022-06-01)

Evidence of Augmented Intrarenal Angiotensinogen Associated With Glomerular Swelling in Gestational Hypertension and Preeclampsia: Clinical Implications
by: Hiten D. Mistry, et al.
Published: (2019-07-01)

A Young Aged Myocardial Infarction with Factor V Leiden Mutation and High Lipoprotein A Level
by: Abdulmelik Yildiz, et al.
Published: (2013-06-01)

No association between MTHFR gene C677T/A1298C polymorphisms, serum folate, vitamin B12, homocysteine levels, and prostate cancer in an Algerian population
by: Rima Mouhoub‐Terrab, et al.
Published: (2023-09-01)

Clinical Case: Atypical Warfarin-induced Skin Necrosis
by: T. V. Kondratieva, et al.
Published: (2019-11-01)

Clinical Case: Atypical Warfarin-induced Skin Necrosis
by: T. V. Kondratieva, et al.
Published: (2019-11-01)

Association between angiotensinogen M235T gene polymorphism and risk of ischemic stroke among the Ethiopian population: a case control study
by: Addisu Melake, et al.
Published: (2023-12-01)

A method for the determination of lipoprotein lipase in postheparin plasma and body tissues utilizing a triolein-coated Celite substrate
by: Israel Posner, et al.
Published: (1971-11-01)

A new enzyme-linked immunosorbent assay system for human serum hepatic triglyceride lipase
by: Kazuya Miyashita, et al.
Published: (2017-08-01)

Overexpression of Intrarenal Renin-Angiotensin System in Human Acute Tubular Necrosis
by: Wei Cao, et al.
Published: (2016-10-01)

Is arginine supplementation effective in preventing preeclampsia in pregnant women?
by: Gabriel Citrangulo, et al.
Published: (2022-05-01)

Pre-existing medical disorders as risk factors for preeclampsia: an exploratory case-control study
by: Linglan Pan, et al.
Published: (2019-10-01)

Mycobacterium bovis: polymerase chain reaction identification in bovine Lymphonode biopsies and genotyping in isolates from Southeast Brazil by spolygotyping and restriction fragment length polymorphism
by: Zanini MS, et al.
Published: (2001-01-01)

Recurrent pregnancy loss: can factor V Leiden mutations be a cause
by: R R N Reddy, et al.
Published: (2019-05-01)

Factores de riesgo de preeclampsia: enfoque inmunoendocrino. Parte I Risk factors for preeclampsia: an immunoendocrine approach. Part I
by: Jeddú Cruz Hernández, et al.
Published: (2007-12-01)

Altered high-density lipoprotein particle structure and antioxidant capacity in preeclampsia
by: Banjac Gorica, et al.
Published: (2023-01-01)

Tumor Necrosis Factor Alpha SNP Variant in Promoter Region G308a, cause Preeclampsia during Pregnancy in Pakistani Women, A Case Control Study
by: Azizah Ziauddin, et al.
Published: (2020-12-01)

Bioensaio rápido de determinação da sensibilidade da acetolactato sintase (ALS) a herbicidas inibidores
by: Patrícia Andrea Monqueiro, et al.
Published: (2001-03-01)

The influence of fasting/refeeding on the lipoprotein lipase activity of adipose tissue and muscle
by: L.M. Botion
Published: (2001-11-01)

Factores de riesgo de preeclampsia: enfoque inmunoendocrino. Parte II Risk factors for preeclampsia: immunoendocrine approach. Part II
by: Jeddú Cruz Hernández, et al.
Published: (2008-03-01)

Association between HLA-A gene polymorphism and early-onset preeclampsia in Chinese pregnant women early-onset
by: Yuanyuan Zheng, et al.
Published: (2020-10-01)